Literature DB >> 15964684

Role of NK-1 neurotransmission in opioid-induced hyperalgesia.

Tamara King1, Luis R Gardell, Ruizhong Wang, Anna Vardanyan, Michael H Ossipov, Philip T Malan, Todd W Vanderah, Stephen P Hunt, Victor J Hruby, Josephine Lai, Frank Porreca.   

Abstract

Opiates are among the most important drugs for treatment of moderate to severe pain and prolonged opiate administration is often required to treat chronic pain states. We investigated the neurobiological actions of sustained opiate administration revealing paradoxical pronociceptive adaptations associated with NK-1 receptor function. Sustained morphine delivered over 6 days elicited hyperalgesia in rats and mice during the period of opiate delivery. Sustained morphine administration increased substance P (SP) and NK-1 receptor expression in the spinal dorsal horn. Sustained morphine treatment also enhanced capsaicin-evoked SP release in vitro, and increased internalization of NK-1 receptors in response to noxious stimulation. While NK-1 receptor internalization was observed primarily in the superficial laminae of placebo-treated rats, NK-1 receptor internalization was seen in both superficial and deep lamina of the dorsal horn in morphine-treated animals. Morphine-induced hyperalgesia was reversed by spinal administration of an NK-1 receptor antagonist in rats and mice, and was observed in wildtype (NK-1(+/+)), but not NK-1 receptor knockout (NK-1(-/-)), mice. These data support a critical role for the NK-1 receptor in the expression of sustained morphine-induced hyperalgesia. Additionally, these data indicate that sustained opiate administration induces changes reminiscent of those associated with inflammatory pain. These opiate-induced changes might produce unintended deleterious actions in the course of pain treatment in patients. Understanding of sustained morphine-induced neurochemical changes will help identify approaches that limit the deleterious actions of opiates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15964684      PMCID: PMC1440305          DOI: 10.1016/j.pain.2005.04.014

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   7.926


  56 in total

1.  Peripheral inflammation is associated with increased dynorphin immunoreactivity in both projection and local circuit neurons in the superficial dorsal horn of the rat lumbar spinal cord.

Authors:  R L Nahin; J L Hylden; M J Iadarola; R Dubner
Journal:  Neurosci Lett       Date:  1989-01-30       Impact factor: 3.046

2.  Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways.

Authors:  Rie Suzuki; Sara Morcuende; Mark Webber; Stephen P Hunt; Anthony H Dickenson
Journal:  Nat Neurosci       Date:  2002-12       Impact factor: 24.884

3.  Hyperalgesia induced by high-dose intrathecal sufentanil in neuropathic pain.

Authors:  J Devulder
Journal:  J Neurosurg Anesthesiol       Date:  1997-04       Impact factor: 3.956

4.  The spinal contribution of substance P to the generation and maintenance of inflammatory hyperalgesia in the rat.

Authors:  Richard J Traub
Journal:  Pain       Date:  1996-09       Impact factor: 6.961

5.  Acute tolerance associated with a single opiate administration: involvement of N-methyl-D-aspartate-dependent pain facilitatory systems.

Authors:  A Larcher; J P Laulin; E Celerier; M Le Moal; G Simonnet
Journal:  Neuroscience       Date:  1998-05       Impact factor: 3.590

6.  Involvement of spinal neurokinin-1 receptors in the maintenance but not induction of carrageenan-induced thermal hyperalgesia in the rat.

Authors:  Yong-Jing Gao; Yu-Qiu Zhang; Zhi-Qi Zhao
Journal:  Brain Res Bull       Date:  2003-10-15       Impact factor: 4.077

7.  Characterization of the interaction of N-acyl-L-tryptophan benzyl ester neurokinin antagonists with the human neurokinin-1 receptor.

Authors:  M A Cascieri; A M Macleod; D Underwood; L L Shiao; E Ber; S Sadowski; H Yu; K J Merchant; C J Swain; C D Strader
Journal:  J Biol Chem       Date:  1994-03-04       Impact factor: 5.157

8.  Spinal cord substance P receptor immunoreactivity increases in both inflammatory and nerve injury models of persistent pain.

Authors:  C Abbadie; J L Brown; P W Mantyh; A I Basbaum
Journal:  Neuroscience       Date:  1996-01       Impact factor: 3.590

9.  Rapid endocytosis of a G protein-coupled receptor: substance P evoked internalization of its receptor in the rat striatum in vivo.

Authors:  P W Mantyh; C J Allen; J R Ghilardi; S D Rogers; C R Mantyh; H Liu; A I Basbaum; S R Vigna; J E Maggio
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

10.  Hyperalgesia produced by intrathecal substance P and related peptides: desensitization and cross desensitization.

Authors:  S M Moochhala; J Sawynok
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

View more
  57 in total

1.  Biological and conformational evaluation of bifunctional compounds for opioid receptor agonists and neurokinin 1 receptor antagonists possessing two penicillamines.

Authors:  Takashi Yamamoto; Padma Nair; Neil E Jacobsen; Vinod Kulkarni; Peg Davis; Shou-Wu Ma; Edita Navratilova; Henry I Yamamura; Todd W Vanderah; Frank Porreca; Josephine Lai; Victor J Hruby
Journal:  J Med Chem       Date:  2010-08-12       Impact factor: 7.446

2.  Opioid-induced latent sensitization in a model of non-inflammatory viscerosomatic hypersensitivity.

Authors:  Bo Lian; Louis Vera-Portocarrero; Tamara King; Michael H Ossipov; Frank Porreca
Journal:  Brain Res       Date:  2010-08-19       Impact factor: 3.252

3.  Tachykinin NK₁ receptor antagonist co-administration attenuates opioid withdrawal-mediated spinal microglia and astrocyte activation.

Authors:  Suneeta Tumati; Tally M Largent-Milnes; Attila I Keresztes; Takashi Yamamoto; Todd W Vanderah; William R Roeske; Victor J Hruby; Eva V Varga
Journal:  Eur J Pharmacol       Date:  2012-06-05       Impact factor: 4.432

Review 4.  Targeting opioid receptor heterodimers: strategies for screening and drug development.

Authors:  Achla Gupta; Fabien M Décaillot; Lakshmi A Devi
Journal:  AAPS J       Date:  2006-03-10       Impact factor: 4.009

5.  Chronic morphine exposure increases the proportion of on-cells in the rostral ventromedial medulla in rats.

Authors:  Ian D Meng; Ichiro Harasawa
Journal:  Life Sci       Date:  2007-02-24       Impact factor: 5.037

6.  Neurokinin 1 and opioid receptors: relationships and interactions in nervous system.

Authors:  Jie Xiao; Si Zeng; Xiangrui Wang; Hasan Babazada; Zhanchun Li; Renyu Liu; Weifeng Yu
Journal:  Transl Perioper Pain Med       Date:  2016

7.  Spinal or systemic TY005, a peptidic opioid agonist/neurokinin 1 antagonist, attenuates pain with reduced tolerance.

Authors:  T M Largent-Milnes; T Yamamoto; P Nair; J W Moulton; V J Hruby; J Lai; F Porreca; T W Vanderah
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

8.  Preprotachykinin-A gene disruption attenuates nociceptive sensitivity after opioid administration and incision by peripheral and spinal mechanisms in mice.

Authors:  Peyman Sahbaie; Xiaoyou Shi; Xiangqi Li; Deyong Liang; Tian-Zhi Guo; Yanli Qiao; David C Yeomans; Wade S Kingery; J David Clark
Journal:  J Pain       Date:  2012-10       Impact factor: 5.820

Review 9.  Changing mechanisms of opiate tolerance and withdrawal during early development: animal models of the human experience.

Authors:  Gordon A Barr; Anika McPhie-Lalmansingh; Jessica Perez; Michelle Riley
Journal:  ILAR J       Date:  2011

10.  Sustained morphine-induced sensitization and loss of diffuse noxious inhibitory controls in dura-sensitive medullary dorsal horn neurons.

Authors:  Akiko Okada-Ogawa; Frank Porreca; Ian D Meng
Journal:  J Neurosci       Date:  2009-12-16       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.